Printer Friendly
The Free Library
19,585,946 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

CML Comments on Stock Listing Status.


ACTON, Mass.--(BUSINESS WIRE)--Nov. 6, 1998--CML Group, Inc. (NYSE NYSE

See: New York Stock Exchange
:CML 1. CML - A query language.

["Towards a Knowledge Description Language", A. Borgida et al, in On Knowledge Base Management Systems, J. Mylopoulos et al eds, Springer 1986].
2. CML - Concurrent ML.
) today reported that it is in discussions with the New York Stock Exchange New York Stock Exchange (NYSE)

World's largest marketplace for securities. The exchange began as an informal meeting of 24 men in 1792 on what is now Wall Street in New York City.
 regarding continued listing of its stock by the Exchange. CML also indicated that it is making contingency plans for the listing of its stock on an alternative national automated trading market, in the event that the NYSE should decide against continued listing of CML's securities at some future point in time. The Company said it intends to provide its investors with continued access to trading, as the Company pursues the plan that it announced on November 5, 1998, to sell the assets of its NordicTrack division, which has filed for protection under Chapter 11 of the Bankruptcy Code Bankruptcy Code may refer to:
  • Bankruptcy in Canada
  • Bankruptcy in the United States
  • Bankruptcy in China
, and to recapitalize and attract growth capital to its profitable Smith & Hawken division.
COPYRIGHT 1998 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1998, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Nov 6, 1998
Words:135
Previous Article:Leading Japanese Retailer Delivers Internet-based Decision Support Applications Developed With Unify VISION AppServer and AppBuilder.
Next Article:SpecTran Denies Allegations Made in Shareholder Suit Filed in Early October.
Topics:



Related Articles
Stopping a killer with interferon?
Trials affirm value of drug.
One-two drug punch trips up leukemia.
Leukemia overpowers drug in two ways.
HEALTH CANADA APPROVES NOVARTIS ORAL CANCER DRUG.
TEST CAPSULE HELPS CHECK LEUKEMIA STUDY SHOWS CANCER PILL BIG SUCCESS.
Chronic-leukemia drug clears a big hurdle. (First-Line Treatment).
Carlton and Tim Lutts's investment newsletters are their own bull market.
Next line of defense: new drugs take on resistant leukemia.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles